NICE selects QRISK to replace Framingham heart risk tool

NICE has signalled the go-ahead for QRISK to replace Framingham as the new cardiovascular risk tool for England and Wales.

In November, NICE decided to delay the publication of its draft lipid modification advice, due last month, so the guideline development group could consider the value of QRISK.

Issued this week, the NICE draft guideline now states that ‘emerging evidence suggests that QRISK gives a better estimation of risk in the general population than the Framingham equations'.

Developed from the EMIS records of 529 GP practices, QRISK incorporates a logorithm of age, ratio of serum total to HDL cholesterol, systolic BP, BMI, family history of cardiovascular disease (CVD), smoking status, Townsend deprivation score and use of one or more BP treatments.

NICE guidance - cardiovascular risk assessment

Comment below and tell us what you think

See all commented articles in our Forums and Blogs section

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in